Depixus is undertaking commercial development of a technology for the fast, accurate, and inexpensive extraction of genetic and epigenetic information from single molecules of DNA and RNA.
The technology is known as SIMDEQ™ (SIngle-molecule Magnetic DEtection and Quantification). It was initially developed at École Normale Supérieure (ENS), one of France's leading 'grandes écoles'.
SIMDEQ™ has a wide range of potential applications across the life-science and medical industries.
Using the SIMDEQ™ platform, it will be possible to identify, count, fully sequence, and epitype many millions of individual molecules of DNA at a high speed and accuracy.
Substantial validation of our technology has already been completed and the first steps towards platform optimisation and commercialisation are currently underway.
New Depixus job opening!
21 Jul 2016
New Depixus job opening
1 Jul 2016
PicoSeq announces corporate name change to Depixus
6 May 2016